The 'pill' may inhibit early cancer, study suggests.
D000367:Age Factors; D001695:Biology; D017691:Caribbean Region; D002477:Cells; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004194:Disease; D005193:Family Planning Services; D007843:Latin America; D008656:Mestranol; D009369:Neoplasms; D009641:Norethynodrel; D010298:Parity; D010342:Patient Acceptance of Health Care; D010827:Physiology; D011647:Puerto Rico; D012106:Research; D014621:Vagina; D014627:Vaginitis
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D009641:Norethynodrel; D008656:Mestranol
Acceptor Characteristics; Age Factors; Biology; Cancer; Caribbean; Clinical Research; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Progestin; Contraceptive Agents--administraction and dosage; Contraceptive Methods--side effects; Contraceptive Usage; Cytologic Effects; Diseases; Family Planning; Latin America; Mestranol--administraction and dosage; Neoplasms; Norethynodrel--administraction and dosage; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Parity; Physiology; Puerto Rico; Research Methodology; Vaginal Abnormalities; Vaginal Desquamate Effects; Vaginitis